Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?

To: musicguy who wrote (7616)	8/27/1998 4:47:00 PM
From: Deeber	Read Replies (1) \| Respond to of 25711

Ok, repost on CYTO... I was a CYTO stockholder back at $8 a share. The company simply does not know how to make money. They have excellent products in Quadramet and Prostascint but they do not know how to profit from them. Marketing is weak, the officers are weak (new CEO now 2x in a year and a new CFO to boot.) Plus, Cellcor may have to go out of business and they stopped research on ALT which was supposed to be their next big one. Too many have been burned on CYTO, it may boune off of 1 like it has in the past, so for a short termer it may be ok. As a company, I do not like it. It may bounce to $1.50...but it will come back to 1 again..you can put that in big bold letters across my forehead. Too many people lost too much $$$ on this...